DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG

Pharmaceutical firm Mankind Pharma on Thursday announced that it has received approval from the Defence Research and Development Organisation (DRDO) to manufacture and market the COVID-19 drug 2-Deoxy-D-Glucose or 2-DG. The drug was developed by Defence Research Development Establishment (DRDE), Gwalior, and clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr. Reddy's Laboratories.

source https://www.newsbytesapp.com/news/india/mankind-pharma-to-manufacture-drdo-s-covid-19-drug-2-dg/story